Company profile for Promethera Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Promethera Biosciences is committed to bring patients life-saving treatments to reduce the need for liver transplantation. Promethera Biosciences’ mission is to bring patients life-saving treatments to reduce the need for liver transplantation. The company is pioneering the development of cell-based therapies that provide both immunomodulatory and anti-fibrotic effects in the liver. The company’s lead clinical program is d...
Promethera Biosciences is committed to bring patients life-saving treatments to reduce the need for liver transplantation. Promethera Biosciences’ mission is to bring patients life-saving treatments to reduce the need for liver transplantation. The company is pioneering the development of cell-based therapies that provide both immunomodulatory and anti-fibrotic effects in the liver. The company’s lead clinical program is derived from a patented allogenic liver cell platform called HepaStem.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Rue Granbonpré 11 Watson & Crick Hill Mont Saint Guibert, Wallonia 1435, BE
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospectrumasia.com/news/26/16322/promethera-explores-therapies-for-liver-diseases-in-china.html

BIOSPECTRUMASIA
20 Jul 2020

https://www.biospectrumasia.com/news/26/16322/promethera-explores-therapies-for-liver-diseases-in-china.html

BIOSPECTRUMASIA
17 Jul 2020

https://www.promethera.com/press-releases/promethera-attracts-sony-innovation-fund-igv-and-pegasus-tech-ventures

PRESS RELEASE
17 Dec 2019

https://www.businesswire.com/news/home/20191110005008/en/Promethera-Biosciences-Presents-Updated-Clinical-Results-AASLD/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

BUSINESSWIRE
11 Nov 2019

https://www.biospectrumasia.com/news/26/14805/promethera-biosciences-spreads-business-activity-to-japan.html

BIOSPECTRUMASIA
03 Nov 2019
Promethera raises €40M to fund trial of NASH cell therapy
Promethera raises €40M to fund trial of NASH cell therapy

07 May 2019

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/promethera-raises-eu40m-to-fund-trial-nash-cell-therapy?utm_source=internal&utm_medium=rss

Nick Paul Taylor FIERCE BIOTECH
07 May 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Promethera Biosciences and get a quotation

Promethera Biosciences is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Azathioprine bulk offered by Promethera Biosciences

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty